Enliven Therapeutics, Inc.
2023 Q2 - 2025 Q4 (11 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 496 | 0.0% | 32,206 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 416 | 0.0% | 20,336 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 408 | 0.0% | 20,330 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 412 | 0.0% | 20,914 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 471 | 0.0% | 20,914 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 485 | 0.0% | 18,974 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 456 | 0.0% | 19,521 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 337 | 0.0% | 19,141 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 281 | 0.0% | 20,330 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 294 | 0.0% | 21,509 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 563 | 0.0% | 27,606 | 6/30/2023 |